Our cGMP Manufacturing Facility in Whippany, NJ

The Whippany, New Jersey facility provides non-GMP and cGMP formulation development to commercial manufacturing services. for over 40 years. Leveraging our excellent compliance track record and broad geographical regulatory reach, we support Innovator biotech or Generic organizations with their complex small molecule needs.

Whippany is perfectly suited to manage your non-gmp pilot scale through to GMP commercial volumes, for a wide range of solid, liquid, and ointment (sterile and non-sterile) dosage forms. The facility includes laboratories for analytical method development and validation, method transfers, QC release, and stability testing as well as microbiology testing. A variety of packaging services are also available.

Pharmaceutical Development

  • Solid dose
  • Liquids
  • Sterile/non-sterile
  • Suppository
  • Packaging
Facility Overview
Facility Size 167,000 SQFT
Regulatory Approval U.S. FDA, U.S. DEA
Production Capabilities
Solid Dosage 3 Billion Units
Liquid 1 Million Liters
Suppository 5 Million Units
Ointments 200,000 KG
Bulk Powder 1,500 KG
Contact Us
30 North Jefferson Road Whippany, NJ 07981 USA